Trading Summary - September 4. The one or more

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
320
Trading Summary - September 4.

The one or more manipulator(s) who have been trying for weeks to buy 52K at .4000 finally succeeded today. Although I still had an invisible bid at .4100, they shorted a paint down of 12K 20 minutes after the open which bypassed my bid - otherwise I would have topped it up - and filled all at .4000. Subsequently, they were able to buy the balance of the 42K they wanted as others panicked. Even then, my bid at .4100 was not completely filled.

Thereafter, an ask buy set at the ask at .4300 was partially filled before the remainder was cancelled and a further .4200 filled on a hidden bid followed by 1000 bought on the ask at .4700.

The good thing is that the one or more people who got the 52K at .4000 did not attempt to stack the ask at a low level under $1.0000 with it and overall they are still not major holders of shares bought in the .4000 > .6000 range.

There was also an update from the CEO today - see earlier post.

There is still almost nothing actually available under the previous high of .7700 - with the first artificially low ask constantly moving between .4700 and .6000.

When the CEO is ready to move the stock up - or the top traders in it decide to - or the company gives a provisional estimate of the value of the first hemp crop when harvested, $EVSV will be back at .7700 in a few individual seconds and on its way into the $1 > $2 range.

Overall, another 62,764 shares were bought today - slightly more than the total for each of the last 2 weeks - again all at levels that will make 150% > 200% profit fairly easily at some point in 2019.

There are now less than 2 weeks until the first hemp crop is harvested.

The following items below the line unchanged since the last Trading Summary:

We now have a confirmed target date of mid-September for the harvest of the first hemp crop at the first of several planned production sites.

The 2019 Q2 was filed on August 7, 2019 in a timely manner (see separate post) and gave a very good description of the holding company $EVSV's current portfolio and partnerships (unable to copy - read in filing).

The top traders in $EVSV aren't going to waste out time nickel and diming trying to fill on the bid when there is so much else going on with Watch List stocks to attend to daily. We will just take out everything on the ask under 1.000 at a time of our choosing.

Top traders who are the movers and shakers of $EVSV will continue the transfer of more of their profits from other trades into $EVSV up until the first hemp crop revenues come out.

Don't expect much to be made available under 1.000.

For those who have been following the "trading successfully through a r/s strategy" since the warning day on January 24, even those who failed to buy in the .4000 > .7150 range over the past 6+ months still have a chance to buy more shares in the .7700 > 1.600 range before the pre-r/s shares come in to play.

The pre-r/s shares from legacy holders aren't going to be significant in number under 2.000 - as is well known to those who were trading in the .0007 > .0011 range pre-r/s for 2 reasons:

- Many amateur iHub mentality traders needlessly sell for a loss as a matter of course as soon as warning is given of a r/s - reducing drastically the number of shares at the former flipper log jam price (which was 1.4000 > 2.000 in "new money".

- Those that kept their shares have had them divided by 2000 - so insignificant in the grand scheme of things bearing in mind we are looking at NASDAQ price levels for $EVSV now.





Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 7

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 3

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 5

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 4

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Shell plc: Recent Share Transactions by Management Team

Updated Category News Views 110

Shell plc made some serious moves back in September 2024 that had traders scratching their heads and looking for the fine print. They let loose a slew of notifications about share transactions by its Persons Discharging Managerial Responsibilities (PDMRs), making waves in the market. This isn’t just corporate fluff; it’s a playbook for transparency and compliance that...

Continue Reading
zSpace Faces Class Action Over IPO Missteps: Key Probe

Updated Category News Views 5

Unpacking the Explosive Allegations Against zSpace You think you're safe diving into augmented reality stocks, and then a bombshell lands. zSpace, Inc. (NASDAQ:ZSPC), a supposed leader in AR and VR educational tech, finds itself in the swirling midst of a class action lawsuit. Investors are rattled, and they're not just buzzing because their portfolios took a hit. There's...

Continue Reading
Transforming Spending: WisdomTree's Innovative Feature Launch

Updated Category News Views 164

WisdomTree Introduces Earn-Until-You-Spend Feature WisdomTree, Inc. (NYSE: WT), a leader in financial innovation, has recently announced a significant enhancement to its user experience with the introduction of a new feature allowing customers to utilize their accrued interest from the WisdomTree Government Money Market Digital Fund (WTGXX) as a funding source for the...

Continue Reading
AVITA Medical Set to Share Third Quarter 2025 Results Soon

Updated Category News Views 163

AVITA Medical to Report Financial Results AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a prominent company in therapeutic acute wound care, has made headlines with its upcoming financial disclosure. The firm is set to unveil its third-quarter financial results for 2025 after the U.S. markets close on the scheduled date. This announcement is anticipated by investors who...

Continue Reading
Hyperscale Data Celebrates Sustainable Growth with Dividends

Updated Category News Views 45

Hyperscale Data's Commendable Dividend Achievement LAS VEGAS — Hyperscale Data, Inc. (NYSE: GPUS) proudly announced it has consistently paid cash dividends for twenty-eight consecutive months on its Series D Preferred Stock. This dividend, amounting to 13.00% annually, equates to approximately $0.2708 for each share, paid monthly. This remarkable track record...

Continue Reading